Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Wright Reports
$75.00
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Zhejiang CONBA Pharmaceutical Co Ltd Announces FY 2013 Q1-Q3 Net Profit Outlook


Tuesday, 8 Oct 2013 08:00pm EDT 

Zhejiang CONBA Pharmaceutical Co Ltd announced that it expects its net profit for the first quarter to third quarter of fiscal year (FY) 2013 to increase approximately by 70%, compared to the net profit of the same period in FY 2012 (RMB 177,860,260.09). The Company cited the increase in sales, the consolidated financial statements, the investment income by sale of stake and assets as well as subsidy received as the main reasons for the forecast.